INTRODUCTION
============

Malaria, which is caused by infection with the hemoprotozoan parasite *Plasmodium*, afflicts approximately 500 million people each year, leading to 2.7 million deaths annually worldwide \[[@B1]\]. Malaria results in diverse clinical outcomes presumably because of dynamic relationships between parasite-expressed virulence factors and individual host responses to these determinants \[[@B2]\]. The last few years have seen a rapid growth in the number of reported genetic associations with susceptibility and resistance to malaria in the host; they are mainly variants in erythrocyte, cytoadherence factor, immune system, and inflammatory genes \[[@B3],[@B5]\]. However, molecular basis of malaria infection remains incompletely defined. Identification of genetic factors in both the host and the parasite involved in malaria susceptibility and resistance would lead not only to a greater understanding of this complex disease, but potentially also to the development of effective medical interventions \[[@B2],[@B6]\].

Interactions between *Plasmodium* and its host hepatocyte factors are of great research interest \[[@B7]-[@B9]\]. On one hand, it is well established that malaria sporozoites exploit hepatocyte growth factor (HGF) and its receptor MET signaling during host invasion \[[@B10]\]. On the other hand, *Plasmodium* is a life cycle-specific disease that includes liver injury at the erythrocyte stage of the parasite \[[@B11]\]. Indeed, both humans and mice suffer from liver injury after infection with the fatal strains *Plasmodium falciparum* (*Pf*) and *P. berghei* (*Pb*) \[[@B12],[@B13]\]. Because *Pb* merozoites do not parasitize liver parenchymal cells in mice, it was proposed that the mechanism of *Pb*-induced liver injury is likely to be caused by the local production of cytokines that activate lymphocytes residing in the liver \[[@B14]\]. Pathologically, malaria-induced mouse liver injury is characterized by dense infiltration of lymphocytes, and the presence of apoptotic and necrotic hepatocytes \[[@B15]\].

*Plasmodium* subtilisin-like protease 2 (subtilase, Sub2) is an essential integral membrane serine protease in both *Pf* and *Pb*. It functions in the shedding of the ectodomain components of 2 surface proteins, membrane surface protein 1 (MSP1), and apical membrane antigen 1 (AMA1), upon host invasion \[[@B16]-[@B18]\]. The importance of the Sub2 gene is evidenced by the demonstration that gene-knock out parasites cannot be recovered \[[@B19]\].

The correlation of HGF and malaria infection is not well understood. In this study, to understand the relationship between the malaria infection-related protein *Pf*-Sub2 and HGF, the *Pf*-Sub2 5\'untranslated region (UTR) was analyzed and its promoter activity was estimated. In addition, the influence of HGF on its promoter activity was analyzed.

MATERIALS AND METHODS
=====================

Parasite manipulations
----------------------

*Pf* 3D7 strain was obtained from Malaria Research and Reference Reagent Resource Center (MR4; Manassas, Virginia, USA; <http://www.mr4.org>). The *Pf* 3D7 culture condition was set according to the MR4 standard protocol. Parasitemia was calculated by counting at least 1,000 cells following staining with Diff Quick (Sysmex, Kobe, Japan).

Cell culture
------------

Cell culture media and components, including fetal bovine serum (FBS), were obtained from Invitrogen (Carlsbad, California, USA). All cells were purchased from the American Type Culture Collection (ATCC, Rockville, Maryland, USA) and were routinely cultured in Dulbecco\'s Modified Eagle\'s Medium (DMEM) supplemented with 10% FBS. HeLa, Huh-7, HepG2, and 293T cells were used for the experiments.

DNA isolation and plasmid vector construction
---------------------------------------------

All plasmids were purified using JETstar2.0 mini and maxiprep Kit (GenoMed, St. Louis, Missouri, USA) according to the manufacturer\'s instructions. *Pf* 3D7 small scale gDNA isolation followed the MR4 protocol. A construct for luciferase activity was based on a pGL3-Basic vector (Promega, Madison, Wisconsin, USA). Two different 5\'upstream sequences flanking the *Pf*-Sub2 gene were amplified from *Pf* 3D7 gDNA with primers. The primers used for -2,567/+32 UTR were F (5\'-ATA[GGTACC]{.ul}TAGAATAGAATAAAATAAATAACC-3\'; *Kpn*I site underlined) and R (5\'-ATA[AAGCTT]{.ul}ATCAAGGAAACCACATAA-3\'; *Hind*III site underlined). The primers used for -1,422/+12 UTR were F (5\'-AA[GGTACC]{.ul}ATGGTATGAGTTCTTTATA-3\'; *Kpn*I site underlined) and R (5\'-AT[GCTAGC]{.ul}AATATTCAGCATTATACGGA-3\'; *Nhe*I site underlined). PCR was performed with a T~GRADIEN~ thermocycler (Biometra, Goettingen, Germany) and the amplified UTR sequences were cloned into a pMDT vector (Takara Bio, Shiga, Japan) and subcloned into a pGL3-Basic vector with *Kpn*I and *Nhe*I/*Hind*III sticky end ligation, generating pGL3-Basic-*Pf*-Sub2 5\'UTR. The other upstream inserts (-329/+12, -668/+12 and -739/+12) were cloned into a pGL3-Basic vector by blunt restriction sites (*EcoR*V, *SnaB*I and *Swa*I) located in the 1.5 kb region upstream of the luciferase gene. The internal control was pSV-β-galactosidase (Promega). All clones were analyzed by restriction mapping and were sequenced by Macrogen (Seoul, South Korea). To study the interactions between *Pf*-Sub2 5\'UTR and HGF, the HGF gene was cloned into pcDNA3 Flag HA vector using the enzymes of BamHI and XhoI.

Transfection and luciferase assay
---------------------------------

pGL3-Basic-*Pf*-Sub2 5\'UTR and pcDNA3 Flag HA HGF vector were co-transfected at a ratio of 2:1 by a standard calcium phosphate co-precipitation method in 6-well plates. Each sample was analyzed in duplicate and each experiment was repeated twice. Luciferase activity was measured using a model LB96V microplate luminometer (Berthold Technologies, Bad Wildbad, Germany) according to the manufacturer\'s instructions. Luciferase activity was normalized with respect to β-galactosidase activity to correct deviation due to transfection efficiencies and cell numbers.

SDS-PAGE and western blot analysis
----------------------------------

Cells were harvested and lysed with RIPA buffer (Pierce, Rockford, Illinois, USA) with freshly added protease inhibitor cocktail (Sigma-Aldrich, St. Louis, Missouri, USA). One hundred nanograms of cell lysate were diluted with a loading buffer that contained a reducing agent, and the proteins were separated by 12% SDS-PAGE and transferred to a polyvinylidene fluoride membrane. Immunoblotting was performed with a 1:200 dilution in 3% bovine serum albumin (BSA) of rabbit polyclonal anti-HA (Dako). The secondary antibody was a 1:1,000 dilution in PBS of polyclonal goat anti-rabbit immunoglobulin G (IgG) conjugated with horseradish peroxidase (HRP) (Dako, Glostrup, Denmark). For proliferating cell nuclear antigen (PCNA) examination, anti-PCNA/HRP monoclonal antibody was used (Dako).

RESULTS
=======

Analysis of *Pf*-Sub2 promoter regions
--------------------------------------

Transcription elements in *Pf*-Sub2 5\'UTR were analyzed. Several transcriptional elements were identified within about 1,453 bp and are listed in [Table 1](#T1){ref-type="table"}. Most transcription elements were 14 TATA boxes but only 1 Oct-1 and c-Myb were observed.

Different transcription activities of upstream regions of *Pf*-Sub2
-------------------------------------------------------------------

We assessed the *Pf*-Sub2 upstream -1,422/+12 UTR 5\'promoter region from -1,422, -739, -668 and -329 to +12. The pGL3-Basic vector cloned with *Pf*-Sub2 5\'UTR driving the luciferase gene and pGL3-Basic-*Pf*-Sub2 5\'UTR was transfected into 293T cells, and its luciferase activities were measured ([Fig. 1](#F1){ref-type="fig"}). In 293T cells, luciferase activities in -1,422/+12, -739/+12 and -668/+12 5\'UTR were 4-7-fold higher than in the pGL3-Basic vector (*P* \< 0.05). Among them, -1,422/+12 UTR exhibited the strongest luciferase activity but -329 to +12 UTR did not exhibit luciferase activity. Luciferase expression was not derived from transfection efficiency. In fact, transfection efficiency of the pGL3-Basic vector determined by use of the SV40 promoter was 1 × 10^7^ in 293T cells.

Influence of exogenous HGF on *Pf*-Sub2 proximal promoter activity in 293T cells
--------------------------------------------------------------------------------

HGF genes were cloned into pcDNA3 HA vector and confirmed by restriction enzyme digestion ([Fig. 2A](#F2){ref-type="fig"}). Western blotting was performed to analyze whether pcDNA3 Flag HA HGF vector was expressed in 293T cells after it was transfected using FuGENE 6 ([Fig. 2B](#F2){ref-type="fig"}). HGF expression was observed, with about a 25 kDa band. To analyze the influence of HGF on the transcriptional activity of 5\'UTR of *Pf*-Sub2 in vitro, co-transfection of pGL3-Basic-*Pf*-Sub2 5\'UTR (-1,422/+12) and pcDNA3 Flag HA HGF vector was performed in 293T cells. The influence of HGF protein onto *Pf*-Sub2 5\'UTR (-1,422/+12) was estimated by the expression of a luciferase gene directed by the *Pf*-Sub2 5\'UTR ([Fig. 3](#F3){ref-type="fig"}). As compared with the control of unexpressed HGF, the HGF protein suppressed luciferase expression by a factor of about 6. It is suggested that HGF controls and interacts with the promoter region of *Pf*-Sub2 gene.

DISCUSSION
==========

*Plasmodium* infects liver tissue, so to understand malaria infection it is necessary to understand the relation between hepatocytes and malaria. However, this process is poorly understood. Sporozoites traverse the cytosol of several hepatocytes before invading one by forming a parasitophorous vacuole \[[@B20]\]. The host responds to the traveling parasites by secreting HGF, which renders hepatocytes susceptible to infection \[[@B10]\]. HGF is known to act as an autocrine cytokine in various cancer cells and precancerous cell types \[[@B21],[@B22]\], but it is not normally expressed by hepatocytes or by most other MET-expressing epithelial cells. However, the mechanism of HGF regulation in mammalians is not fully understood.

Moreover, clarifying transcription regulation in *Plasmodium* genome is onerous because of the genome\'s abnormal AT-richness \[[@B23],[@B24]\]. Nonetheless, *Plasmodium* genes are organized similarly to those in eukaryotes and are also monocistronically transcribed \[[@B25]-[@B27]\], implying the presence of regulatory sequence elements flanking the coding regions \[[@B28],[@B29]\]. For example, the *Pf* multidrug resistance gene upstream region can be induced at the level of transcription by antimalarial drugs in chloroquine sensitive parasites \[[@B30]\]. Our results obtained from upstream transcriptional activities of *Pf*-Sub2 demonstrate that the proximal promoter of *Pf*-Sub2 is influenced by the HGF. 5\'UTR were analyzed for transcriptional elements of which 14 TATA boxes and other elements, *e.g.*, one Oct-1 and c-Myb were observed. Deletion mutants of 5\'UTR of *Pf*-Sub2 were constructed and -1,422/+12 UTR exhibited the strongest promoter activity. To understand the interaction of HGF and 5\'UTR of *Pf*-Sub2, 2 vectors of the molecules are cloned and co-transfected into cells. HGF expression was suppressed by 5\'untranslated region of the *Pf*-Sub2 promoter. In these results, -1,422 to +12 UTR of *Pf*-Sub2 was applied and contained all transcriptional elements in [Table 1](#T1){ref-type="table"}. Therefore, further study will be performed what positions of -1,422 to +12 UTR are important to inhibit the HGF expression. Although the effect of HGF on malaria gene expression in cultured cells may be indirect or atypical, the present results indicate the feasibility of regulation of gene(s) important in malaria invasion through host-parasite interaction. In fact, both recombination in subtelomeric regions and chromosome internal rearrangements under host pressure have proven that the parasite can interact with its vertebrate host \[[@B31]-[@B33]\]. Specific upstream regions are important in the activity of the protease. Future studies will be aimed at elucidating the details of the role of HGF in malaria sensitivity/resistance and how Sub2 gene expression is influenced by the host HGF signaling cascade.
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![The promoter activity analysis of pGL3-Basic-*Pf*-Sub2 5\'UTR vector. The promoter activities of 4 different pGL3-Basic-*Pf*-Sub2 5\'UTR constructs were evaluated by luciferase expression (Relative Luciferase Unit, RLU). β-galactosidase activity was used to normalize transfection efficiency.](kjp-48-291-g001){#F1}

![Construction of pcDNA3 HA HGF vector and HGF-expression. HGF was inserted into pcDNA3 HA vector using *Bam*HI and *Xho*I restriction enzyme sites. DNA fragments were observed for HGF cloning by restriction enzymes digestion (A) Lane 1, *Hind*III; lane 2, *Hind*III + *Xba*I. (B) Shows the expression of 25-kDa-sized HGF. The diagram of pcDNA3 HA HGF vector of about 7.4 kb which contains restriction enzyme sites is provided as supplementary data.](kjp-48-291-g002){#F2}

![Influence of HGF onto the promoter activity of pGL3-Basic-*Pf*-Sub2 5\'UTR vector. pGL3-Basic-*Pf*-Sub2 5\'UTR (-1,422/+12) and pcDNA3 HA HGF vector were co-transfected into 293T cells. Its promoter activity was estimated by luciferase expression (RLU). β-galactosidase activity was used to normalize transfection efficiency.](kjp-48-291-g003){#F3}
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